Detection of acetyltransferase modification of kanamycin, an aminoglycoside antibiotic, in bacteria using ultrahigh-performance liquid chromatography tandem mass spectrometry

Rapid Communications in Mass Spectrometry : RCM
Johnny J Perez, Chin-Yi Chen

Abstract

The occurrence of antibiotic-resistant bacteria is a worldwide issue that has the potential, if not addressed, to eliminate classes of antibiotics that have extended life expectancy in the last century. An approach to confront this threat is the development of technologies that greatly accelerate the detection of antibiotic resistance to minimize unnecessary treatment involving antibiotics. Development of an analytical method for rapid detection of aminoglycoside resistance using liquid chromatography/mass spectrometry (LC/MS) has not been reported in the literature and is described here. A strain of Escherichia coli carrying a plasmid encoding an aminoglycoside-modifide enzyme (N-acetyltransferase) was incubated with kanamycin, an aminoglycoside. The antibiotic and its modified form were observed using LC/MS. An ABSciex QTrap 6500+ was used for kinetic and quantitative analysis and high-resolution structural elucidation was performed using a Thermo Fisher Q-Exactive hybrid quadrupole-orbitrap mass spectrometer. Detection of kanamycin modification was achieved in less than an hour of incubation. Calibration curves for both modified and unmodified kanamycin from 0.5 to 50 μg mL-1 were obtained. Generation and depletion of modifi...Continue Reading

References

Oct 1, 1977·Journal of General Microbiology·T D BrownH L Kornberg
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·A PhilipponG Jacoby
Mar 11, 1998·Rapid Communications in Mass Spectrometry : RCM·K J WelhamD S Ashton
Dec 5, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·D A Stead
May 10, 2002·British Journal of Biomedical Science·Thomas Marshall, Katherine M Williams
Apr 8, 2003·Applied Microbiology and Biotechnology·R P Elander
Jun 21, 2005·Emerging Infectious Diseases·Kunikazu YamaneYoshichika Arakawa
Dec 8, 2005·Biochemistry·Maria L B Magalhaes, John S Blanchard
Jan 5, 2006·Applied Microbiology and Biotechnology·S Jana, J K Deb
Jan 17, 2007·The Journal of Antimicrobial Chemotherapy·Pierre BogaertsYouri Glupczynski
Jul 31, 2007·Applied Microbiology and Biotechnology·Laxmi Prasad ThapaJae Kyung Sohng
Feb 11, 2012·Journal of Clinical Microbiology·A GrundtM Neumaier
Aug 2, 2012·Revue Scientifique Et Technique·T Lambert
Dec 4, 2015·Applied Microbiology and Biotechnology·G Jaimee, P M Halami

❮ Previous
Next ❯

Citations

Nov 7, 2019·Journal of Clinical Pathology·Angela W S FungVathany Kulasingam
Apr 10, 2020·PLoS Pathogens·R Christopher D FurnissGerald Larrouy-Maumus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.